共 97 条
Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy
被引:28
作者:
Aziz, Aisha
[1
]
Rehman, Urushi
[1
]
Sheikh, Afsana
[1
]
Abourehab, Mohammed A. S.
[2
,3
]
Kesharwani, Prashant
[1
,4
]
机构:
[1] Jamia Hamdard, Dept Pharmaceut, Sch Pharmaceut Educ & Res, New Delhi 110062, India
[2] Umm Al Qura Univ, Coll Pharm, Dept Pharmaceut, Mecca, Saudi Arabia
[3] Minia Univ, Coll Pharm, Dept Pharmaceut & Ind Pharm, Al Minya, Egypt
[4] Chandigarh Univ, Univ Inst Pharma Sci, Mohali, Punjab, India
关键词:
CRISPR;
Cas;
cancer;
lipid-based nanoparticles;
solid-lipid nanoparticles;
niosomes;
lipid carrier;
CAS9;
MESSENGER-RNA;
PROMISING NANOCARRIERS;
IN-VITRO;
NANOPARTICLES;
DENDRIMER;
EPIDEMIOLOGY;
CRISPR-CAS9;
ETIOLOGY;
CARRIERS;
SYSTEMS;
D O I:
10.1080/09205063.2022.2121592
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
CRISPR/Cas mediated gene-editing has opened new avenues for therapies that show great potential for treating or curing cancers, genetic disorders, and microbial infections such as HIV. CRISPR/Cas9 tool is highly efficacious in revolutionizing the advent of genome editing; however, its efficient and safe delivery is a major hurdle due to its cellular impermeability and instability. Nano vectors could be explored to scale up the safe and effective delivery of CRISPR/Cas9. This review highlights the importance of CRISPR/Cas9 genome editing system in cancer treatment along with the effect of lipid-based nanoparticles in its safe delivery to cancer cells. The solid-lipid nanoparticles, nanostructured lipid carrier, lipid nanoparticles and niosomes have shown great effect in the delivery of CRISPR compounds to the cancer cells. The design and genome editing application in cancer therapy has been discussed along with the future concern and prospects of lipid nanoparticle based CRISPR/Cas9 has been focused toward the end.
引用
收藏
页码:398 / 418
页数:21
相关论文